Oisin Biotechnologies Company
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Last Funding Type:
seed round
Funding Status:
Seed
Headquarters:
Seattle, Washington, United States
Founded Date:
2014
Investor Type:
For Profit
Last Funding Date:
May 27, 2021
Total Funding:
7.1M
Technology:
Geroscience
Employee Number:
11-50
Number Of Exists:
11-50
Investors Number:
6
Industry:
Biopharma, Biotechnology, Gene therapy, Medical